List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 950 studies with search of:   United States, Vermont
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
21 Completed flt3L in Treating Patients With Acute Myeloid Leukemia
Condition: Leukemia
Intervention: Drug: recombinant flt3 ligand
22 Terminated A Randomized Study to Evaluate FK962 in Subjects With Mild to Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: FK962
23 Completed Combination Chemotherapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Has Spread to the Lymph Nodes
Condition: Breast Cancer
Interventions: Drug: cyclophosphamide;   Drug: docetaxel;   Drug: doxorubicin hydrochloride;   Drug: paclitaxel;   Drug: tamoxifen citrate;   Procedure: radiation therapy
24 Completed Pentosan Polysulfate in Treating Patients With Gastrointestinal Disturbance Caused by Radiation Therapy
Condition: Cancer-Related Problem/Condition
Interventions: Drug: pentosan polysulfate sodium;   Procedure: quality-of-life assessment
25 Completed Combination Chemotherapy in Treating Patients With Relapsed or Refractory Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Drug: doxorubicin hydrochloride;   Drug: topotecan hydrochloride
26 Active, not recruiting Radiation Therapy, Temozolomide, and Irinotecan in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: irinotecan hydrochloride;   Drug: temozolomide;   Procedure: adjuvant therapy;   Procedure: radiation therapy
27 Completed Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Drug: gemcitabine hydrochloride;   Drug: pegylated liposomal doxorubicin hydrochloride;   Drug: vinorelbine ditartrate
28 Active, not recruiting Homoharringtonine Compared With Hydroxyurea for Chronic Myelogenous Leukemia That Has Not Responded to Interferon Alfa
Condition: Leukemia
Interventions: Drug: hydroxyurea;   Drug: omacetaxine mepesuccinate
29 Active, not recruiting Pilocarpine in Preventing Mucositis and Dry Mouth in Patients Receiving Radiation Therapy for Head and Neck Cancer
Conditions: Cancer-Related Problem/Condition;   Head and Neck Cancer
Intervention: Drug: pilocarpine hydrochloride
30 Active, not recruiting Interleukin-12 and Interferon Alfa in Treating Patients With Metastatic Malignant Melanoma
Condition: Melanoma (Skin)
Interventions: Drug: recombinant interferon alfa;   Drug: recombinant interleukin-12
31 Active, not recruiting Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
Condition: Prostate Cancer
Interventions: Drug: docetaxel;   Drug: estramustine phosphate sodium;   Drug: exisulind
32 Active, not recruiting Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell Lymphoma
Conditions: Graft Versus Host Disease;   Lymphoma
Interventions: Drug: carmustine;   Drug: cytarabine;   Drug: etoposide;   Drug: melphalan;   Drug: methotrexate;   Drug: sargramostim;   Drug: tacrolimus;   Drug: therapeutic allogeneic lymphocytes;   Procedure: peripheral blood stem cell transplantation
33 Completed Vaccine Plus Interleukin-2 in Treating Patients With Advanced Melanoma
Condition: Melanoma (Skin)
Interventions: Drug: aldesleukin;   Drug: gp100 antigen;   Drug: incomplete Freund's adjuvant
34 Completed Imatinib Mesylate in Treating Patients With Progressive, Refractory, or Recurrent Stage II or Stage III Testicular or Ovarian Cancer
Conditions: Ovarian Cancer;   Testicular Germ Cell Tumor
Intervention: Drug: imatinib mesylate
35 Completed Combination Chemotherapy and Exisulind in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Drug: carboplatin;   Drug: etoposide;   Drug: exisulind
36 Active, not recruiting Fludarabine Followed by Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia
Condition: Leukemia
Interventions: Drug: alemtuzumab;   Drug: fludarabine phosphate
37 Completed Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Previously Untreated Aggressive Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Drug: EPOCH regimen;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: filgrastim;   Drug: prednisone;   Drug: vincristine sulfate
38 Active, not recruiting Fludarabine With or Without Cyclophosphamide in Treating Patients With Chronic Lymphocytic Leukemia
Condition: Leukemia
Interventions: Drug: cyclophosphamide;   Drug: fludarabine phosphate
39 Active, not recruiting Gemtuzumab Ozogamicin and High-Dose Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Condition: Leukemia
Interventions: Drug: cytarabine;   Drug: gemtuzumab ozogamicin
40 Completed Capecitabine and Gemcitabine in Treating Patients With Metastatic Kidney Cancer
Condition: Kidney Cancer
Interventions: Drug: capecitabine;   Drug: gemcitabine hydrochloride

Previous Page (1-20) Studies Shown (21-40) Next (41-60)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services